
Abstract Objectives Central precocious puberty (CPP) requires timely differentiation from benign puberty variants (BPV). While the gonadotropin-releasing hormone (GnRH) stimulation test is the gold standard, it is invasive and costly. This study evaluated whether pelvic ultrasound parameters combined with basal luteinizing hormone (LH) could reliably distinguish CPP from BPV. Methods This retrospective study included 153 girls aged 5–9 years (CPP, n=85; BPV, n=68). Multivariate logistic regression, receiver operating characteristic (ROC) curve analysis across three age strata (<7, 7 to <8, and ≥8 years), and mediation analysis were performed. Results Basal LH, uterine anteroposterior diameter (AP), and mean antral follicle count (AFC) were independent predictors of CPP. The combined AP+AFC+LH model achieved an AUC of 0.905 (sensitivity 81.2 %, specificity 82.4 %). Age-stratified analysis showed improving accuracy with older age: AUC 0.862 (<7 years), 0.912 (7 to <8 years), and 0.937 (≥8 years). Mediation analysis demonstrated that basal LH partially mediated the effects of both AP and AFC on CPP. Conclusions The combination of uterine AP diameter, AFC, and basal LH provides a robust, minimally invasive screening tool for CPP, with diagnostic accuracy increasing with age. This simplified model may reduce reliance on GnRH stimulation testing, particularly in girls ≥7 years.
Abstract Objectives To highlight the diagnostic challenges of childhood insulinoma and the complementary role of GLP-1 receptor–targeted imaging in localizing a small pancreatic lesion. Case presentation A 12-year-old boy had a history of recurrent episodes suggestive of hypoglycemia reportedly beginning at approximately 4 years of age, with reported glucose concentrations as low as 15–20 mg/dL and associated night sweats. Diagnostic evaluation was fragmented over several years due to frequent family relocations. During a critical sample, plasma glucose was 37 mg/dL, with insulin 105.2 µIU/mL and C-peptide 5.48 ng/mL, supporting endogenous hyperinsulinemic hypoglycemia. MRI demonstrated a small lesion in the pancreatic body. 68 Ga-Exendin-4 PET/CT demonstrated focal GLP-1 receptor–targeted uptake corresponding to the pancreatic lesion, with a delayed SUVmax of 9.1. The patient underwent open surgical enucleation. Histopathology demonstrated a 1.7-cm well-differentiated pancreatic neuroendocrine tumor, WHO Grade 1, with a Ki-67 index of 1 %, negative margins, and no necrosis, lymphovascular, or perineural invasion. Postoperatively, glucose concentrations remained normal. Conclusions Persistent or unexplained hypoglycemia in children warrants consideration of insulinoma when endogenous hyperinsulinemic hypoglycemia is demonstrated. In this case, GLP-1 receptor–targeted imaging provided complementary functional localization alongside MRI and supported focused curative surgery.
Objectives ENPP1 deficiency encompasses a phenotypic spectrum from generalized arterial calcification of infancy (GACI) to autosomal recessive hypophosphatemic rickets type 2 (ARHR2), and phenotypic variability has been reported even among individuals carrying the same variants; however, the extent of intrafamilial phenotypic concordance remains unclear. Case presentation Case 1, a 20-month-old boy, presented with genu varum and fibroblast growth factor 23-mediated hypophosphatemic rickets. Genetic testing identified compound heterozygous ENPP1 variants, c.937_938insT (p.Gln313LeufsTer18), and a deletion involving exons 8–13. Ultrasonography revealed valvular calcifications, carotid intimal irregularity, and nephrocalcinosis. Case 2, his younger brother, developed fetal hydrops, diffuse cardiovascular calcification, and severe cardiac dysfunction in late gestation and died shortly after preterm birth. Postmortem examination demonstrated extensive vascular calcification consistent with GACI; genetic testing identified the same variants. A sibling-based literature review of genetically confirmed cases with shared biallelic ENPP1 variants identified 21 publications describing 26 unrelated families. Including the present family, 27 families comprising 61 affected individuals were analyzed; 24 families (88.9 %) had concordant phenotypes, whereas three (11.1 %) had discordant phenotypes. Among 19 individuals who presented with hypophosphatemia or ARHR2 without a documented history of GACI and underwent cardiovascular, calcification, and/or hearing assessment, 14 had abnormal findings. Conclusions Documented GACI status was generally concordant among affected siblings. Frequent cardiovascular, calcification-related, and/or hearing abnormalities in patients presenting with hypophosphatemia or ARHR2 without a documented history of GACI highlight the importance of multisystem assessment and support GACI and ARHR2 as overlapping manifestations within the ENPP1 deficiency spectrum.
OBJECTIVES: Central precocious puberty (CPP) may have psychosocial implications for girls and their mothers. We evaluated changes in maternal psychological distress during gonadotropin-releasing hormone analogue (GnRHa) therapy and associations with child emotional, behavioral, and peer-related functioning. METHODS: This prospective observational study included 40 girls with confirmed CPP and their mothers. Eligibility required documented progressive breast development before age 8, clinical progression, and biochemical central activation; isolated thelarche, isolated pubarche, and lipomastia were excluded. Child psychosocial measures and baseline maternal Depression Anxiety Stress Scale-21 (DASS-21) were completed at the same visit. Maternal DASS-21 was repeated at variable times during ongoing GnRHa therapy. RESULTS: Mean total maternal DASS-21 score decreased from 13.38 ± 10.58 to 7.13 ± 8.15 (p<0.001). Maternal total DASS-21 showed moderate positive associations with total internalizing symptoms (ρ=0.501, p<0.001) and several RCADS-P domains; the total internalizing association remained after adjustment for BMI SDS (partial ρ=0.510, p<0.001). Among behavioral and social outcomes, maternal total DASS-21 was associated with hyperactivity, while exploratory maternal anxiety analyses showed associations with the ADHD Index and hyperactivity. DASS-21 change was not associated with age at diagnosis or reassessment interval. CONCLUSIONS: Maternal psychological distress decreased over time during GnRHa therapy and showed moderate associations with mother-reported emotional symptoms in girls with confirmed CPP. These findings support individualized, family-centered psychosocial assessment as part of CPP care.
Abstract Objectives Juvenile obesity is a major risk factor for the development of type 2 diabetes. KiCK is a 1-year outpatient pediatric obesity therapy program at the AUF DER BULT Children’s and Youth Hospital. In addition to multiprofessional obesity training, clinical and laboratory data are collected at the beginning and end of the program, and a standardized 6-min walking test (6MWT) is carried out. Methods BMI, laboratory parameters, daily media usage time, and the data of the 6-MWT of the program participants in the years 2009–2012 (“A”), 2012–2015 (“B”), and 2018–2019 (“C”) were recorded, and the differences between the three groups were analyzed. Results Group A included n=64 children (mean age 12.0; 40.6 % female), group B included n=104 children (mean age 11.7; 55.8 % female), and group C included n=131 children (mean age 11.9; 58 % female). BMI-SDS improved constantly in all three groups (A: 2.4 vs. 2.3 (p=0.009); B: 2.4 vs. 2.2 (p=0.003); C: 2.4 vs. 2.1 (p=0.001)). Obesity therapy significantly improved the walking distance in group B in the 6-MWT (B: 574 m vs. 621 m (p=<0.001)). Conclusions The significant improvement in BMI-SDS over decades shows the constant program’s contribution to improved weight outcomes in children and adolescents during the periods studied.